| 08/14/2026 8:05 PM | Ikarian Capital, LLC (1778253) Filed by Novogen (1075880) Subject | Form SCHEDULE 13G/A | |
| 07/08/2026 3:57 PM | APPLE ROBERT F (1054942) Reporting Novogen (1075880) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/08/2026 3:57 PM | Cain David (2125950) Reporting Novogen (1075880) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/08/2026 3:58 PM | Davidson Ebru (2135805) Reporting Novogen (1075880) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/08/2026 3:58 PM | Bonacorda Jeffrey (2115111) Reporting Novogen (1075880) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/08/2026 3:59 PM | Friend John E. II (1704021) Reporting Novogen (1075880) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/08/2026 3:59 PM | Coffey Steven R. S. (2121676) Reporting Novogen (1075880) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/23/2026 5:47 PM | Novogen (1075880) Issuer Rao Sudha (2132027) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/23/2026 5:47 PM | Novogen (1075880) Issuer Levine James E. (1463151) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 5:52 PM | Novogen (1075880) Issuer Levine James E. (1463151) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 06/03/2026 7:20 PM | Davidson Ebru (2135805) Reporting Novogen (1075880) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for KZIA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Novogen and its competitors with MarketBeat's FREE daily newsletter.
|
| 06/02/2026 8:00 AM | Novogen (1075880) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/02/2026 8:01 AM | Novogen (1075880) Filer | Form 424B3 | |
| 06/02/2026 8:02 AM | Novogen (1075880) Filer | Form 424B3 | |
| 06/02/2026 8:03 AM | Novogen (1075880) Filer | Form 424B3 | |
| 06/02/2026 8:04 AM | Novogen (1075880) Filer | Form 424B3 | |
| 05/27/2026 9:31 AM | Chernett Jorey (2042077) Filed by Novogen (1075880) Subject | Form SCHEDULE 13G/A | |
| 05/26/2026 7:00 AM | Novogen (1075880) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/26/2026 7:01 AM | Novogen (1075880) Filer | Form 424B3 | |
| 05/26/2026 7:02 AM | Novogen (1075880) Filer | Form 424B3 | |
| 05/26/2026 7:03 AM | Novogen (1075880) Filer | Form 424B3 | |
| 05/26/2026 7:04 AM | Novogen (1075880) Filer | Form 424B3 | |
| 05/19/2026 12:07 PM | Novogen (1075880) Issuer Rao Sudha (2132027) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/27/2026 7:30 AM | Novogen (1075880) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/15/2026 7:30 AM | Novogen (1075880) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/15/2026 7:31 AM | Novogen (1075880) Filer | Form 424B3 | |
| 04/15/2026 7:32 AM | Novogen (1075880) Filer | Form 424B3 | |
| 04/15/2026 7:33 AM | Novogen (1075880) Filer | Form 424B3 | |
| 04/15/2026 7:34 AM | Novogen (1075880) Filer | Form 424B3 | |
| 04/13/2026 4:24 PM | Novogen (1075880) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/13/2026 4:25 PM | Novogen (1075880) Filer | Form 424B3 | |
| 04/13/2026 4:25 PM | Novogen (1075880) Filer | Form 424B3 | |
| 04/13/2026 4:25 PM | Novogen (1075880) Filer | Form 424B3 | |
| 04/13/2026 4:26 PM | Novogen (1075880) Filer | Form 424B3 | |
| 04/09/2026 4:24 PM | Friend John E. II (1704021) Reporting Novogen (1075880) Issuer | Form 3/A | |
| 04/01/2026 8:20 AM | Cain David (2125950) Reporting Novogen (1075880) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/31/2026 3:56 PM | Novogen (1075880) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/31/2026 1:36 PM | Chernett Jorey (2042077) Filed by Novogen (1075880) Subject | Form SCHEDULE 13G/A | |
| 03/30/2026 7:30 PM | Alumni Capital LP (1912606) Filed by Novogen (1075880) Subject | Form SCHEDULE 13G/A | |
| 03/29/2026 11:15 PM | Novogen (1075880) Filer | Form EFFECT | |
| 03/30/2026 5:08 AM | Novogen (1075880) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
The $15 Gold Fund That Pays Up to $1,152/Month (Ad) Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required.
Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. Discover the gold income fund before the next payout date |
| 03/19/2026 4:14 PM | Novogen (1075880) Filer | Form 424B3 | |
| 03/19/2026 4:17 PM | Novogen (1075880) Filer | Form 424B3 | |
| 03/19/2026 4:19 PM | Novogen (1075880) Filer | Form 424B3 | |
| 03/19/2026 4:09 PM | Novogen (1075880) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/19/2026 4:12 PM | Novogen (1075880) Filer | Form 424B3 | |
| 03/18/2026 6:18 PM | Coffey Steven R. S. (2121676) Reporting Novogen (1075880) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 5:32 PM | Novogen (1075880) Issuer Simpson Jeremy (2121674) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 5:35 PM | Friend John E. II (1704021) Reporting Novogen (1075880) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 4:55 PM | Bonacorda Jeffrey (2115111) Reporting Novogen (1075880) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 4:47 PM | APPLE ROBERT F (1054942) Reporting Novogen (1075880) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/17/2026 4:47 PM | Ikarian Capital, LLC (1778253) Filed by Novogen (1075880) Subject | Form SCHEDULE 13G | |
| 01/27/2026 7:20 AM | Novogen (1075880) Filer | Form 424B3 | |
| 01/27/2026 7:22 AM | Novogen (1075880) Filer | Form 424B3 | |
| 01/27/2026 7:23 AM | Novogen (1075880) Filer | Form 424B3 | |
| 01/27/2026 7:25 AM | Novogen (1075880) Filer | Form 424B3 | |
| 01/27/2026 7:10 AM | Novogen (1075880) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/23/2026 3:00 PM | Novogen (1075880) Subject Lynwood Capital Management Inc. (1846412) Filed by | Form SCHEDULE 13G | |
| 12/23/2025 4:27 PM | Novogen (1075880) Filer | Form 424B3 | |
| 12/23/2025 4:27 PM | Novogen (1075880) Filer | Form 424B3 | |
| 12/22/2025 11:15 PM | Novogen (1075880) Filer | Form EFFECT | |
| 12/22/2025 11:15 PM | Novogen (1075880) Filer | Form EFFECT | |
| 12/19/2025 3:44 PM | Novogen (1075880) Filer | Form F-1 Registration statement for securities of certain foreign private issuers | |
| 12/19/2025 3:45 PM | Novogen (1075880) Filer | Form F-1/A | |
| 12/19/2025 3:46 PM | Novogen (1075880) Filer | Form POS AM | |
| 12/19/2025 3:46 PM | Novogen (1075880) Filer | Form POS AM | |
| 12/19/2025 3:01 PM | Novogen (1075880) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/18/2025 1:21 PM | Novogen (1075880) Filer | Form D Notice of Exempt Offering of Securities | |
| 12/10/2025 3:11 PM | Novogen (1075880) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/05/2025 3:05 PM | Novogen (1075880) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/02/2025 3:05 PM | Novogen (1075880) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/18/2025 3:18 PM | Novogen (1075880) Filer | Form 424B3 | |
| 11/18/2025 3:19 PM | Novogen (1075880) Filer | Form 424B3 | |
| 11/18/2025 3:20 PM | Novogen (1075880) Filer | Form 424B3 | |
| 11/14/2025 11:48 AM | Dauntless Investment Group, LLC (2044285) Filed by Novogen (1075880) Subject | Form SCHEDULE 13G/A | |
| 10/31/2025 3:01 PM | Novogen (1075880) Filer | Form NT 20-F | |
| 10/07/2025 4:17 PM | Novogen (1075880) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/07/2025 4:19 PM | Novogen (1075880) Filer | Form 424B3 | |
| 10/07/2025 4:22 PM | Novogen (1075880) Filer | Form 424B3 | |
| 10/07/2025 4:24 PM | Novogen (1075880) Filer | Form 424B3 | |
| 10/02/2025 7:55 AM | Novogen (1075880) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/02/2025 7:58 AM | Novogen (1075880) Filer | Form 424B3 | |
| 10/02/2025 8:01 AM | Novogen (1075880) Filer | Form 424B3 | |
| 10/02/2025 8:04 AM | Novogen (1075880) Filer | Form 424B3 | |
| 09/30/2025 7:00 AM | Novogen (1075880) Filer | Form F-1 Registration statement for securities of certain foreign private issuers | |
| 09/12/2025 5:52 AM | Alumni Capital LP (1912606) Filed by Novogen (1075880) Subject | Form SCHEDULE 13G/A | |
| 09/11/2025 8:23 AM | Novogen (1075880) Filer | Form 424B3 | |
| 09/11/2025 8:11 AM | Novogen (1075880) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/11/2025 8:18 AM | Novogen (1075880) Filer | Form 424B3 | |
| 09/11/2025 8:20 AM | Novogen (1075880) Filer | Form 424B3 | |
| 08/14/2025 1:57 PM | Novogen (1075880) Filer | Form D Notice of Exempt Offering of Securities | |
AI insiders stockpile guns, gold & gas masks (Ad) Keith Kaplan, CEO of TradeSmith, has spent more than $17 million studying AI since 2022. He says a major shift in the AI market is approaching, and time is short to prepare.
Kaplan points to August 31st as a key turning point for AI investing. He argues the next phase will separate winners from losers, and reveals what he's watching instead of big names like Nvidia. See Keith Kaplan's full AI market briefing before August 31st |